CVS profit gets boost from delayed elective surgeries during coronavirus

FAN Editor

CVS Health Corp. profit spiked 55 percent in the three months through June, buoyed by lower benefit costs as insurance policyholders delayed elective surgeries and other medical procedures to avoid infection during the COVID-19 pandemic.

Continue Reading Below

The Woonsocket, Rhode Island-based pharmacy health care provider earned $2.99 billion, or an adjusted $2.64 per share, as revenue rose 3 percent to $65.3 billion. Wall Street analysts surveyed by Refinitiv were expecting adjusted earnings of $1.93 a share on revenue of $64.2 billion.

“Our earnings in this environment demonstrate the strength of our strategy and the power of our diversified business model,” CEO Larry Merlo said in a statement. The drusgtore chain, which manages prescription-drug benefits through its Caremark subsidiary, expanded into health insurance with its 2018 acquisition of Aetna.

The company raised its full-year 2020 adjusted earnings outlook to a range of $7.14 to $7.27 per share, up from $7.04 to $7.17.

CLICK HERE TO READ MORE ON FOX BUSINESS

This story is developing. Check back for updates.

Free America Network Articles

Leave a Reply

Next Post

Disney shares pop after it reveals 100 million streaming subscribers and plans to launch a new streaming service

Disney reported mixed earnings for its fiscal third quarter on Tuesday, but the stock rose 5% in extended trading after CEO Bob Chapek announced a new streaming service and said Disney+ subscribers will get exclusive access to the release of “Mulan,” which has been repeatedly delayed due to theater closures. […]